Literature DB >> 17630980

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

Sam Gandy1, Yun-wu Zhang, Annat Ikin, Stephen D Schmidt, Alexey Bogush, Efrat Levy, Roxanne Sheffield, Ralph A Nixon, Francesca-Fang Liao, Paul M Mathews, Huaxi Xu, Michelle E Ehrlich.   

Abstract

Studies in continuously cultured cells have established that familial Alzheimer's disease (FAD) mutant presenilin 1 (PS1) delays exit of the amyloid precursor protein (APP) from the trans-Golgi network (TGN). Here we report the first description of PS1-regulated APP trafficking in cerebral neurons in culture and in vivo. Using neurons from transgenic mice or a cell-free APP transport vesicle biogenesis system derived from the TGN of those neurons, we demonstrated that knocking-in an FAD-associated mutant PS1 transgene was associated with delayed kinetics of APP arrival at the cell surface. Apparently, this delay was at least partially attributable to impaired exit of APP from the TGN, which was documented in the cell-free APP transport vesicle biogenesis assay. To extend the study to APP and carboxyl terminal fragment (CTF) trafficking to cerebral neurons in vivo, we performed subcellular fractionation of brains from APP transgenic mice, some of which carried a second transgene encoding an FAD-associated mutant form of PS1. The presence of the FAD mutant PS1 was associated with a slight shift in the subcellular localization of both holoAPP and APP CTFs toward iodixanol density gradient fractions that were enriched in a marker for the TGN. In a parallel set of experiments, we used an APP : furin chimeric protein strategy to test the effect of artificially forcing TGN concentration of an APP : furin chimera that could be a substrate for beta- and gamma-cleavage. This chimeric substrate generated excess Abeta42 when compared with wildtype APP. These data indicate that the presence of an FAD-associated mutant human PS1 transgene is associated with redistribution of the APP and APP CTFs in brain neurons toward TGN-enriched fractions. The chimera experiment suggests that TGN-enrichment of a beta-/gamma-secretase substrate may play an integral role in the action of mutant PS1 to elevate brain levels of Abeta42.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630980     DOI: 10.1111/j.1471-4159.2007.04587.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.

Authors:  Sam Gandy; Adam J Simon; John W Steele; Alex L Lublin; James J Lah; Lary C Walker; Allan I Levey; Grant A Krafft; Efrat Levy; Frédéric Checler; Charles Glabe; Warren B Bilker; Ted Abel; James Schmeidler; Michelle E Ehrlich
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

2.  Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations.

Authors:  Grace Woodruff; Sol M Reyna; Mariah Dunlap; Rik Van Der Kant; Julia A Callender; Jessica E Young; Elizabeth A Roberts; Lawrence S B Goldstein
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

3.  Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.

Authors:  Can Zhang; Andrew Browne; Daniel Child; Rudolph E Tanzi
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

4.  Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.

Authors:  Jeffrey L Frost; Kevin X Le; Holger Cynis; Elizabeth Ekpo; Martin Kleinschmidt; Roberta M Palmour; Frank R Ervin; Shikha Snigdha; Carl W Cotman; Takaomi C Saido; Robert J Vassar; Peter St George-Hyslop; Tsuneya Ikezu; Stephan Schilling; Hans-Ulrich Demuth; Cynthia A Lemere
Journal:  Am J Pathol       Date:  2013-06-07       Impact factor: 4.307

Review 5.  The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.

Authors:  M A Greenough
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

6.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

7.  Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein.

Authors:  Can Zhang; Andrew Browne; Daniel Child; Jason R Divito; Jesse A Stevenson; Rudolph E Tanzi
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration.

Authors:  Qi Chen; Charles A Peto; G Diane Shelton; Andrew Mizisin; Paul E Sawchenko; David Schubert
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

9.  Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice.

Authors:  Yan Hou; Marwa A Aboukhatwa; De-Liang Lei; Kebreten Manaye; Ikhlas Khan; Yuan Luo
Journal:  Neuropharmacology       Date:  2009-11-14       Impact factor: 5.250

10.  Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Naoki Kaneko; Rie Yamamoto; Taka-Aki Sato; Koichi Tanaka
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.